首页 | 本学科首页   官方微博 | 高级检索  
     

重组人生长激素治疗肝硬化低蛋白血症的临床观察
摘    要:

关 键 词:重组人生长激素 治疗 肝硬化 低蛋白血症 临床观察

Clinical observation of recombinant growth hormone therapy for liver cirrhosis with hypoproteinemia]
Shao-jun Liu,Wu-liang Tang,Shou-rong Shen. Clinical observation of recombinant growth hormone therapy for liver cirrhosis with hypoproteinemia][J]. Bulletin of Hunan Medical University, 2003, 28(4): 398-400
Authors:Shao-jun Liu  Wu-liang Tang  Shou-rong Shen
Affiliation:Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Abstract:OBJECTIVE: To assess the effect of recombinant growth hormone (rhGH) therapy for liver cirrhosis patients with hypoproteinemia. METHODS: Fifteen patients with liver cirrhosis were treated with rhGH (4 U per day) for 7 days and 15 controls were given human albumin (10 g) for every other day (altogether 3 times). Albumin was measured one day before the treatment, and on day 1, 10, 14, and 28 after the treatment. RESULTS: After 7 days of rhGH administration, the albumin level of the patients was significantly higher and the function lasted longer than those of patients treated with human albumin (P < 0.05). CONCLUSION: Exogenous rhGH in treating hypoproteinemia in patients with liver cirrhosis is more effective than human albumin.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号